PDE10A helps brain cells fine tune chemical messages that support smooth movement, learning, and behavior. This gene plays an important role in parts of the brain that coordinate movement by breaking down signal molecules after they have done their job. If the PDE10A gene does not work properly, signaling can become less controlled, and some people may develop involuntary movements, changes in muscle tone, or developmental and learning difficulties. Most people only hear about the PDE10A gene when it appears on genetic testing.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes carry the instructions for producing proteins, which are the working parts of cells. Other genes mainly guide when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
PDE10AGene function
What if the gene works
The PDE10A gene helps brain cells control chemical messages by breaking down cAMP and cGMP, two signaling molecules. This supports smooth communication in movement circuits.
Risk
What if the gene does not work
Variants in the PDE10A gene are linked to a rare movement condition, often causing childhood-onset chorea or dystonia. Effects can range from milder abnormal movements to earlier, more limiting symptoms, sometimes with learning or developmental differences.
Treatment
What does that mean for your treatment
For pathogenic variants in the PDE10A gene, no PDE10A-specific treatment or management approach is currently established. The PDE10A gene is being studied as a brain signaling target, and PDE10A-related changes on brain scans have also been explored as a biomarker in conditions such as Huntington disease.
Conditions associated with PDE10A
Gene function
What if the gene works
Your brain cells use the PDE10A gene to fine tune chemical signals so they stay controlled. It is especially active in deep brain areas that help coordinate movement, habits, and reward. Understanding how the PDE10A gene helps nerve cells communicate makes its role in everyday brain function easier to see.
The PDE10A gene gives cells instructions to make an enzyme that breaks down cAMP and cGMP, two small signal molecules inside cells. This helps messages switch off at the right time instead of lasting too long.
By lowering cAMP and cGMP levels, the PDE10A gene fine tunes how strongly some nerve cells respond to incoming messages. This supports more controlled timing and balance in cell to cell signaling.
This gene is especially active in brain cells within the striatum, a region that helps guide movement, habits, and reward. Its protein supports steady signaling there as dopamine and glutamate, two common brain messengers, are processed.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
PDE10A gene variants can change enzyme activity in brain cells by making the protein less stable, less active, or, in some cases, unusually active. More disruptive variants may sharply alter cAMP and cGMP, two messenger signals that help nerve cells communicate, while milder variants may leave some function intact. This range in functional impact can help explain why symptoms linked to variants in the PDE10A gene may begin earlier or be more noticeable in some people than in others.
How variants are linked to conditions
Pathogenic variants in the PDE10A gene are linked to childhood-onset chorea, a rare movement condition that causes involuntary, dance-like movements. Some people also have developmental delay or learning difficulties. Because this is a rare inherited condition, finding a disease-causing PDE10A variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal part of human biology and are found throughout the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well described variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the PDE10A gene. In families with a disease-causing change in PDE10A, risk is mainly shaped by the inherited gene change itself rather than by lifestyle or everyday exposures. People with concerns about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of PDE10A variants
The inheritance pattern for PDE10A-related conditions can differ depending on the specific variant and condition involved. Some PDE10A gene variants are inherited in an autosomal dominant way, which means a parent carrying the variant can pass it to each child with a 50% chance. Other PDE10A gene variants have been reported in an autosomal recessive pattern, where a child inherits one altered copy from each parent. In practical terms, how PDE10A variants are inherited depends on whether a person has one disease-causing copy or two.
What does my PDE10A result mean for my family?
For PDE10A, what this means for relatives depends on the exact result, because this gene has been linked to more than one inherited movement condition. In some families, a changed copy can run in a dominant pattern, so close relatives may also carry it and may want to discuss whether testing is appropriate. In other families, the condition appears only when both copies are changed, which can mean parents are healthy carriers and siblings could also be carriers or be affected.
Genetic information
Genetic testing
How you find out about variants
PDE10A genetic testing usually uses a blood or saliva sample. A lab reads the DNA code to look for variants in the PDE10A gene, often as part of a movement disorder panel or broader sequencing. Results can show whether a variant was found and how clearly it explains symptoms.
When should I consider getting a genetic test?
Genetic testing for the PDE10A gene may be considered when someone has unexplained movement problems that start in childhood or early adult life, especially ongoing jerky or dance-like movements. It can also be helpful when similar symptoms are seen in other family members.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you varies based on the condition and the type of variant involved. Factors such as lifestyle, environment, age, and medical history also affect how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or handle a drug differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects. These differences are common and are one reason medication response can vary from person to person. Genetics is only one part of the picture, alongside age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect a person’s response to medications. It looks at relationships between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. If you want to explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the PDE10A gene
When should I seek medical advice?
At this time, this gene is not used in a broadly confirmed way to guide how medicines are chosen or how well they work, so any concerns about side effects, new symptoms, or treatment changes are best discussed with your doctor.
History
In the late 1990s, researchers identified the PDE10A gene while mapping a family of genes involved in cell signaling. Early work drew attention because PDE10A was found at especially high levels in the striatum, a brain region long linked to movement and behavior. From these first observations, research expanded steadily, and the gene became a focus in neuroscience and drug development, especially in studies of schizophrenia and Huntington disease. Interest grew further when rare variants in the PDE10A gene were later linked to inherited movement conditions, including childhood onset chorea. These findings helped move PDE10A from a laboratory discovery to a gene with recognized clinical relevance.